Blogs - Page 86 of 92 - Awesome Penny Stocks

Blog

VPCO – Vapor Corp. what are the insiders saying?

What Insiders Say About Vapor Corp

Vapor Corp. (OTC:VPCO) stock is currently trading at about $0.00 and lots of rating firms seem to have a target price set on the stock. The median 12-month price target of 1 analysts covering the company is $6.00, which suggests the stock could still gain more than 100 percent.

The highest analyst price target is $6.00, which implies a gain of 100 percent. And roundups of analyst notes show that 0 are rating the stock a buy while 0 rate VPCO a strong buy. There are 0 equity research firms suggesting a Hold and 0 consider it Sell.

Several executives took part in recent insider activity for the stock. Its 10% Owner MARXE AUSTIN W & GREENHOUSE DA sold 50,000 company shares for $288000, in a transaction on 2014-02-14. Following the transaction, the 10% Owner is left with a stake of 288 shares, currently valued at $0. Meanwhile, Dir of Issuer sole opertng sub Galazan Isaac purchased 0 shares worth $51000.5, through a transaction dated 2013-10-29.

Following the completion of the transaction, the insider is left with a stake of 0 shares, amounting $0. VPCO CFO Press Harlan also purchased 0 shares, at a stock price of $9799804. This transaction occurred on 2013-10-29 totals $159000.46. After this transaction, the insider’s stake stands at 0 shares, with a market value of $0
Insiders own 32.04 percent of the stock. Doron Ziv is one of the largest insider shareholders in Vapor Corp. (OTC:VPCO) , according to U.S. Securities and Exchange Commission (SEC) filings. The insider owns 7,514,604 shares which have current market value of around $0.Jeffrey Elliot Holman is another major inside shareholder in the company. The insider owns 5,805,548 shares as of 2073.41%, currently worth $0. Isaac Galazan is ranked as third insider holder of the stock. This insider holds 846,302 shares with a market value around $0 as of recent close.

Share This:

Read More

STEV – Stevia Corp is Looking Strong

Stevia Corp is Looking Strong

Stevia Corp (OTCMKTS:STEV) is exchanging lower in late sessions on developing volume. STEV is a stock with a background marked by huge moves running from well under a dime to $0.339 highs this time a year ago.

On April 20 STEV reported natural chemist and previous MD Anderson Cancer Researcher Dennis Hill has acknowledged a position on Stevia Corp’s. recently framed Advisory Panel. Dennis Hill has separated himself as being one of only a handful few individuals on record on the planet that accomplished finish reduction of growth exclusively using cannabis without traditional tumor treatment, for example, radiation or chemotherapy.

Stevia Corp (OTCMKTS:STEV) is a ranch administration organization and medicinal services organization concentrated on growing very dietary, high esteem items through exclusive plant reproducing, astounding rural approachs and inventive post-reap strategies.
STEV works various divisions in stevia and mechanical hemp and just achieved benefit as indicated by their keep going 10Q documented on November 19.

The energy on stevia is obvious and numerous foresee it is bound to end up the primary road workhorse characteristic high strength sweetener available. Stevia is a sweetener and sugar substitute separated from the leaves of the plant species Stevia rebaudiana.

The dynamic mixes of stevia are steviol glycosides, which have up to 150 times the sweetness of sugar is warmth stable, pH-stable, and not fermentable. These steviosides negligibly affect blood glucose, which makes stevia alluring to individuals on sugar controlled weight control plans. Stevia’s taste has a slower onset and longer span than that of sugar, and some of its concentrates may have a biting or licorice-like delayed flavor impression at high fixations.

STEV President George Blankenbaker who has lived in Asia for a considerable length of time initiated the Company’s advancement of high Reb-A Stevia cultivating in Vietnam and in addition secured essential circulation through PureCircle, the industry’s driving stevia refiner.

Share This:

Read More

SIPC – Sipp Industries is Heading in The Right Direction

Sipp Industries is Heading in The Right Direction

Sipp Industries (SIPC) is a multifaceted corporation with a focus in technology, biotechnology and consumer products. We specialize in the vertical integration of profitable retail and emerging entities to create increased value to our shareholders through synergistic savings in operations.

2016 has, up to this point, been an exceptionally beneficial and transformational year for SIPC. Having at first entered the market as a mass hemp fixing provider to different item producers and nearby Colorado make bottling works, for example, Crazy Mountain Brewing and Ute Pass Brewing Co., Management observed rapidly that the Company was remaining at the edge of a colossal open door. In acknowledgment of the potential market for unmistakably detailed hemp mixed lager, the Company chose to leave on the plan, assembling and conveyance of a restrictive line of hemp and Cannabidiol (CBD) brew.
SIPC’s solid prospect for achievement was found at an effective 4/20 occasion at Ute Pass Brewing Co. where supporters and shareholders inspected five unmistakable assortments of hemp and CBD brew. Subsequent to accepting good audits for its extraordinary taste, auxiliary Major Hemp prepared to decide and execute the best technique to take this activity to the following level, which included collaboration with potential permitting parties, fabricating accomplices, and wholesalers.

Over the past quarter, SIPC has turned out to be acutely mindful of the benefits of elite responsibility for hemp and CBD formulas, trademarks, and discount licenses. By moving to secure the Company’s exclusive rights, Sipp Industries takes full control of its own predetermination as the business extends. As terms are finished with legitimate guidance, Sipp Industries will build up full restrictive rights and control of the Company’s hemp and CBD lager formulas. The Company hopes to have the capacity to make a formal declaration before the month’s over.

SIPC’s auxiliary hemp brew activity point of convergence is the foundation of expanded creation limit. Keeping in mind the end goal to take care of the demand prerequisites of significant brew merchants, the organization must demonstrate it can reliably satisfy expansive requests. Real Hemp President Ted Jorgensen expressed: “In suspicion of the way that we must be set up to take care of a rapidly developing demand, we have been proactive in the hunt down able accomplices. In the wake of talking different prospects, we have chosen a brewer that surpasses the majority of our desires and prerequisites.”

Share This:

Read More

PUGE – Puget Technologies Has An Interesting Business Model

Puget Technologies Has An Interesting Business Model

Puget Technologies, Inc. (OTC: PUGE) is a development-stage company. The Company is engaged in developing and marketing of consumer-oriented products ready for commercialization. The Company’s subsidiaries include B-29 Energy, Inc. (B-29), which is in the development stage. B-29 is engaged in the business of development and distribution of energy products.

B-29’s products include B-29 Energy Drink and various medical marijuana products, which are under development. B-29 produces these products through its subsidiary, Cannabis Biotech. The Company is also engaged in the development of three dimensional (3D) printing and supporting technologies for My3DP personal printer. The applications of the Company’s products are in various sectors, which include crafting, jewelry and domestic goods.

PUGE recently announces the formation of Cannabis BioTech, through which it is entering the growing medical marijuana industry. Cannabis BioTech is poised to become an emerging front-runner in the cutting-edge field of cannabinoid science.

Cannabis BioTech is in the research and development stages of creating a cannabis (marijuana) derived medicinal product line. These products are intended to deliver the benefits of marijuana without the need to smoke or inhale it.

President and CEO of PUGE Ron Leyland said, “We are pleased to complete the establishment of Cannabis BioTech. We are confident our new subsidiary will fill a void in this rapidly increasing market among many medical marijuana license holders who have no desire to ‘smoke pot.’” He added, “Patients will feel comfortable using our products because great care will be taken to determine proper dosages and protocols, ensuring strict quality standards.”
According to The Wall Street Street Journal MarketWatch, many analysts expect the $1.7 billion U.S. medical marijuana market to quadruple in size during the next five years.

Share This:

Read More

NDEV – NOVUS ACQ and DEV

NOVUS ACQ and DEV Is Moving Forward

NOVUS ACQ and DEV (OTCMKTS:NDEV) is a smaller scale top name that has seized the consideration of dealers amid the stock’s sharp rising. The move comes in the wake of news that the organization, which trumpets itself as “country’s first medicinal services protection transporter in the restorative cannabis field”, has finished its scope impression for California, undoubtedly its biggest and most imperative market.

Late activity has seen somewhat under 360% added to share estimations of the posting over the previous month of activity. This is symbolic of the stock. Shares of NDEV stock have prove sudden upward instability on numerous earlier events. Likewise, the name has seen a pop in enthusiasm, as exchange volume levels have as of late pushed somewhat more than 330% over the normal volume levels in play in this stock over the more extended term.

This is especially essential with a buoy in play that is tight — under 14M shares. It’s something the veterans know to key on: inclining exchanging movement can overpower accessible supply in a stock with this kind of little buoy, prompting to an upward burst in costs, pretty much as we have been seeing generally.

NDEV charges itself as a supplier of restorative arranges and related projects for hemp and cannabis patients in the United States.

NDEV ‘s protection arrange additionally covers doctor visits, dental, lasik, hearing, diabetic supplies, lab administrations, remedies, and other integrative drugs. Furthermore, it gives protection arranges that cover general obligation, business auto ruck, laborers pay, property, umbrella, abundance risk, ecological, mistakes and oversights, and others, and in addition offers strength line of protection items.

Novus Acquisition and Development Corp. offers its items through operators and computerized advertisers.

The organization was some time ago referred to as previously known as BrandQuest Development Group, Inc. furthermore, changed its name to Novus Acquisition and Development Corp. in April 2009. Novus Acquisition and Development Corp. was established in 1996 and is headquartered in Miami, Florida.

Share This:

Read More

NGBL – Notis Global Inc

Notis Global Could Shine With a New Look

Notis Global Inc (OTCMKTS:NGBL) has another name and another image as it hopes to eradicate the stench that was Medbox Inc. Medbox left financial specialists with expansive misfortunes as the organization went on a rush of weakening and socked it to the normal speculator. As Notis Global, the organization is trusting that it can get new financial specialists and inspire speculators to disregard its past.

While Notis Global is still a similar old Medbox, the organization is hoping to profit by the restored enthusiasm for pot stocks. We’ve been discussing this as far back as 2016 moved around. Around 14 states could legitimize pot this year, grown-up utilize cannabis or potentially both, either at the polling booth or through state assemblies. While it’s dicey every one of those states will be fruitful, there’s a decent possibility no less than a modest bunch will legitimize in 2016. No other single year has offered such mind boggling guarantee as far as the sheer volume of states that could authorize, on account of other spearheading pot markets and developing backing for cannabis all in all.

The ArcView Group recently reported that lawful offers of cannabis developed to $5.4 billion in 2015, up from $4.6 billion in 2014. Request is required to stay solid this year and the examination firm gauges offers of $6.7 billion. Nonmedicinal grown-up utilize represented $998 million of the aggregate deals in 2015, up from $351 million in 2014, as per the ArcView/New Frontier report rundown.

The most astonishing perspective for us at Insider Financial is the way that maryjane stocks have failed to meet expectations the significant market lists. This part is likely the quickest developing industry in America at this moment and the vast majority of people in general organizations in the space are exchanging for pennies. With the potential enthusiasm originating from all kinds of different backgrounds, we think you’ll see base fishers searching for a place to contribute.

In conjunction with its accomplices, including Whole Hemp Company, Notis is on track to be one of the biggest U.S. cultivators, processors and income makers of hemp items from seed to deal. With development offices situated in Pueblo, Colo., Notis utilizes best cultivating works on, developing item outside and in nursery offices. Notis is situated to wind up a main U.S. based supplier of Cannabidiol (CBD) oil with a devoted deals group, driving income and offering the item for sale to the public. Through key associations, Notis is working with a portion of the world’s driving scientists on ceaseless developments of CBD-related therapeutic items to help patients around the globe.

Share This:

Read More

NCAP – Northsight Capital becoming interesting

New Appointments Makes Northsight Capital More Interesting

Northsight Capital, Inc. (OTCBB: NCAP) is comprised of a portfolio of online marijuana-related websites that are developed and operated by the company. These sites incorporate many aspects of the marijuana industry. The company intends to provide its audience with a means to stay informed on the industry’s most cutting-edge marijuana-related innovations and legislation.

NCAP’s most dynamic concept, WeedDepot.com, provides consumers with a geo-targeted map directory of medical and recreational dispensaries, head shops, doctors, attorneys and more within the marijuana industry. The Weed Depot app can be downloaded for free at the iTunes Store and Google Play. Weed Depot has an entire platform of content suited for every aspect of advertising and marketing to consumers from all businesses in the cannabis industry.

NCAP declared as of late the arrangement of John B. Hollister as CEO. Mr. Hollister brings over 25 years of business administration and raising support involvement in related pharmaceutical, biotech and therapeutic gadget fields including SmithKline Beecham and Amgen. Most as of late, as the CEO and Director of NEMUS Bioscience, a biopharmaceutical organization creating cannabis-determined pharmaceutical items, Hollister effectively brought over $7M up in working capital, including the latest round of $5M.

As a Director and Global Commercial Leader in Oncology at Amgen, Hollister was in charge of driving a few multidisciplinary groups creating oncology atoms, and stage IV administration of Neulasta. He has a solid working learning of all aspects of item advancement and commercialization. Hollister was CEO and Chairman of restorative gadget organization EGG Spectrum International, and Senior VP for an analytic organization, Tethys Bioscience. Furthermore, Hollister is a long-standing board part for the main philanthropy in emotional wellness look into, the Brain and Behavior Research Foundation. Hollister got his college degree in Economics from Stanford University and his MBA from the Drucker School of Management at the Claremont Graduate University.

Hollister expressed: “With the quickly developing perspective of medicinal and individual utilization of cannabis, comes an enormous requirement for access to data. Northsight Capital has assembled an accumulation of capable areas and has worked out a virtual group of assets for all things maryjane. We are exceptionally amped up for interfacing purchasers with the data, items, occasions and administrations they might want.”

Share This:

Read More

MNTR – MENTOR CAPITAL INC COM

MENTOR CAPITAL Is on Momentum

MENTOR CAPITAL INC COM NPV (OTCMKTS:MNTR) has been running up the graphs supported by an account with its foundations solidly in the organization’s late September declaration of a concurrence with GreenVision Systems, an Emerging Puerto Rico Medical Cannabis and Hemp Farming Company, as a key customer for consultative administrations.

Late activity has seen 250% attached on to share valuing for the posting in the previous month. This is significant of the stock. MNTR has a past filled with sensational energizes. Also, the organization has seen a pop in enthusiasm, as exchange volume levels have as of late pushed surpassing 510% as time goes by and large. It pays to observe this reality because of the small buoy measure in the stock (of 0 shares). As insightful brokers are very much aware, a hop in normal every day exchange volume in a stock with a confined buoy can unleash firecrackers as supply is pressed.

MNTR trumpets itself as a private value firm work in acquisitions. The firm gives detached value financing and liquidity to littler organizations and proprietors in the therapeutic, maryjane and social utilize cannabis organizations.

It puts resources into rack IPOs and open and privately owned businesses and looks to give open market access to proprietors of little privately owned businesses. If there should be an occurrence of rack IPOs, the firm likes to put resources into organizations with deals more prominent than $40 million. It likes to take critical position in its portfolio organizations. The firm puts just in organizations that have profit.
MNTR was established in 1985 and is situated in Ramona, California. MNTR looks to come close by and help private restorative maryjane and cannabis organizations and their originators in meeting their liquidity and money related destinations, to add insurance for financial specialists and to brood private cannabis organizations.

Share This:

Read More

MJNA – Medicinal Marijuana

Medicinal Marijuana Is on The Verge of Rebound

Medicinal Marijuana, Inc. (OTCPK:MJNA) shut today at $0.10, an ascent of 376% since the stock shut at $0.063 on Oct 14, 2016. With almost 2.95 Billion shares extraordinary, it now has a market capitalization of $667.8 Million, which in view of MJNA’s basics and fleeting prospects, is a few times too high, verging on the silly.

MJNA’s sharp ascent in the stock cost in the course of recent weeks is likely because of most recent recreational cannabis votes in California, Arizona, Maine, Massachusetts, and Nevada, these activities go into law. This is on the grounds that MJNA is principally an organization that offers items in light of CBD (Cannabidiol) separated from modern hemp stalks and seeds, and has expressed that until pot is governmentally legitimate, it won’t offer items that incorporate THC (Tetrahydrocannabinol,) and still states on its site that it doesn’t offer items that damage the U.S. Controlled Substances Act.

Indeed, even the entry of restorative cannabis laws in North Dakota, Montana, Arkansas and Florida could be a negative for MJNA, in light of the fact that since the organization has practical experience in CBD removed from the stalks and seeds of modern hemp, it’s totally conceivable that it could lose piece of the overall industry to contenders that concentrate it from the buds of high-CBD strains of pot, for example, Charlotte’s Web (since renamed as therapeutic hemp).

Restorative Marijuana’s financials are expected in the following week, yet as of the end of 2Q/16, they positively were not the sort of numbers that would warrant an almost $700M advertise top. For the initial six months of 2016, MJNA reported aggregate income of $3.26M, which was down 42.6% from the $5.8M reported in 1H/15. The Net Operating Loss in the main portion of 2016 was roughly $1.5M, and because of different one-time charges and compose downs, the 1H/16 net misfortune was about $15M.

Share This:

Read More

MDCN – Medican Enterprises Inc

Consider Medican Enterprises, But Be Cautious

Medican Enterprises Inc (OTCMKTS: MDCN) is floundering without end in sub penny arrive. This one exchanges at a small amount of its previous self since the 10 for 1 switch split.
On August 4 the Company declared a vital deals advertising arrangement with Music Quest Entertainment. Following a broad, year long assessment of various vital chances to create dynamic deals, the progressions that we are organizing will guarantee that Medican Enterprises will quicken conveying top notch items and deals.
“As MDCN pushes ahead, we are significantly appreciative for our old and new consultants’ direction and bolster that has been offered in the course of the most recent a while,” said Ken Williams, CEO.

MSCN s a bio-pharmaceutical organization concentrated on creating, dispersing and advertising pharmaceutical review cannabis to the developing worldwide restorative maryjane showcase. It’s entirely claimed backup Medican Systems Inc. is an industry pioneer in the plan, development and operation of Medical Marijuana and Cultivation Centers crosswise over Canada.

MDCN) works in the Medical Marijuana part which is a quickly developing industry worth $2.34 billion in 2014 and as per Greenwave Advisors, if every one of the 50 states sanction MJ and the central government went with the same pattern and made it lawful, the joined deals for Medical and Recreational MJ would achieve higher than 35Bln USD by 2020.
All the energy on MDCN is about the 67,000 square foot office in Phoenix, Arizona which the organization arrangements to rent as a pot developing and distribution center office to authorized cultivators.

The modern building sits on 2.55 sections of land of mechanical zoned arrive. The foreseen last price tag for the property is $2,340,310 and an end is arranged amid the primary quarter of 2015 pending, among other shutting conditions, a change to zone the working for the development of weed.

The procurement of this property will dispatch Medican’s land and renting administrations business under which the organization would rent land that is equipped with turnkey answers for lawfully agreeable developing offices to authorized producers. At current market rates the property is evaluated to create yearly rent incomes of around $1,400,000.

Share This:

Read More